ClinicalTrials.gg
Not yet recruitingNCT07372183Updated Jan 28, 2026

Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers

An observational study in Smoking, Cigarette, Alveolar Bone Grafting and Wound Healing, sponsored by Marquette University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-28.

Sponsored by Marquette University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this study is to evaluate bone wound healing following extraction and alveolar ridge preservation (bone graft and membrane) clinically, histologically and in relation to gene expression in smokers and non-smokers. Data from a small group of participants will be analyzed after age-matched subjects undergo extraction and alveolar ridge preservation prior to implant placement. The data obtained in this pilot study will be used to plan a full-fledged study involving a larger number of smoking and non-smoking participants to compare the two groups.

Read the detailed description

All research procedures will start after IRB approval. Patients of the Graduate Periodontics Clinic in need of extraction, bone graft and membrane will be recruited. There will be two groups (smokers and non-smokers) and their demographic and social, periodontal, surgery-related, anatomical and healing variables as well as patient-reported outcomes will be recorded at different time points (immediately before, during and immediately after surgery and 1, 2, 6 weeks and 4 months) in order to evaluate wound healing outcomes and differences between the groups. The demographic and social variables evaluated are age, gender, race, medical history, medications, smoking (via interview and breath test-smokerlyzer) and alcohol consumption (via interview). The periodontal variables are tooth mobility, probing depth, attachment level, gingival and plaque index. The surgery-related variables include intraoperative complications, duration of procedure, anesthetic amount, type and approach and operator experience. The anatomical variables are bone height and width (buccolingual and buccal dimension), bone density (in Cone Beam Computed Tomographies - CBCTs) and gingival width and thickness. The healing variables include wound opening (tested clinically and in photos), bleeding, grafting material discharge, flap necrosis, loose sutures, and temporary restoration adjustment. The patient-reported outcomes are Oral Health Impact Questionnaire-14 (OHIP-14), Visual Analogue Scale (VAS) for pain, swelling and difficulty of mouth opening. At 4 months during the implant placement appointment, a bone core will be harvested via a 3D printed surgical guide based on virtual CBCT planning. The core willl be used of microCT and histological analysis as well as total RNA extraction and RNA sequencing.

02

Conditions studied

  • Smoking, Cigarette
  • Alveolar Bone Grafting
  • Wound Healing
  • Bone Healing
  • Tooth Extraction Site Healing

Browse trials for

03

In context

Cigarette Smoking

475 studies on the registry are indexed under Cigarette Smoking; 86 are open to participants now.

This study's planned enrollment of 12 is below the median of 120 across 57 observational studies indexed under Cigarette Smoking.

Browse Cigarette Smoking studies →

Lead sponsor

Marquette University is the lead sponsor of 38 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients scheduled for tooth extraction and alveolar ridge preservation (bone graft and membrane) in the Graduate Periodontics Clinic at Marquette University School of Dentistry.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (18-75 years)
  • Good general health (controlled conditions)
  • Smokers (≥10 cigarettes/day for ≥5 years) and never smokers. Confirmation of smoking status will be done via use of a smokerlyzer. The cut-off point for distinguishing smokers from non-smokers is 8 carbon monoxide parts per million (ppm).
  • Periodontal status: periodontal health, gingivitis on intact or reduced periodontium, treated periodontitis
  • Intact post-extraction bony walls or less than 50% bone dehiscence
  • Distance at least 8 mm of vertical bone height between bone crest and anatomical structures (i.e. sinus floor, inferior alveolar nerve (IAN) canal, mental foramen)
  • Extracted tooth root in the same three-dimensional position as the future implant placement so that the bone core can be taken from a site totally within the confines of the former tooth socket without inclusion of surrounding native alveolar bone
  • Scheduled for single tooth extraction with bone graft placement and membrane

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled periodontal disease
  • Uncontrolled systemic disease
  • Pregnancy
  • Use of therapy and/or medication that impairs wound healing (e.g., bisphosphonates, , chemotherapy, radiotherapy etc.)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Smokers

    Subjects are qualified as smokers if they report smoking ≥10 cigarettes/day for ≥5 years, and maintain a 8ppm carbon monoxide concentration or higher via smokerlyzer test.

    Other: observational study

  • Non-smokers

    Subjects qualify as nonsmokers if they have never smoked and upon confirmation by the smokerlyzer test of carbon monoxide concentation of less than 8ppm.

    Other: observational study

Interventions

  • Otherobservational study

    Observational study; alveolar ridge preservation

06

What researchers measure

Primary outcomes

  1. Clinical Parameters

    bone width

    Time frame: Measured before surgery, during surgery and at 4 months

  2. Clinical Parameters

    bone height

    Time frame: Measured before surgery, during surgery and at 4 months

Secondary outcomes

  1. Genetic Parameters

    RNA transcriptomic analysis

    Time frame: Bone samples harvested at 4 months

  2. Histological Parameters

    Histological analysis of bone cores: %mineralized bone

    Time frame: Samples harvested at 4 months

  3. Histological Parameters

    Histological analysis of bone cores: %osteoid

    Time frame: Samples harvested at 4 months

  4. Histological Parameters

    Histological analysis of bone cores: %residual bone graft

    Time frame: Samples harvested at 4 months

  5. Histological Parameters

    Histological analysis of bone cores: %soft tissue

    Time frame: Samples harvested at 4 months

  6. Histological Parameters

    Histological analysis of bone cores: numbers of osteoblasts and osteoclasts

    Time frame: Samples harvested at 4 months

  7. Micro-CT Parameters

    Histological analysis of bone cores: bone mineral density

    Time frame: Samples harvested at 4 months

  8. Micro-CT Parameters

    Histological analysis of bone cores: tissue mineral density

    Time frame: Samples harvested at 4 months

  9. Micro-CT Parameters

    Histological analysis of bone cores: bone volume / tissue volume (BV/TV)

    Time frame: Samples harvested at 4 months

  10. Micro-CT Parameters

    Histological analysis of bone cores: trabecular number

    Time frame: Samples harvested at 4 months

  11. Micro-CT Parameters

    Histological analysis of bone cores: trabecular separation

    Time frame: Samples harvested at 4 months

  12. Micro-CT Parameters

    Histological analysis of bone cores: trabecular thickness

    Time frame: Samples harvested at 4 months

  13. Patient-reported Parameters

    Oral Health Impact Profile -14 (OHIP-14). Range from 0 (no impact) to 56 (most severe impact).

    Time frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months

  14. Patient-reported Parameters

    VAS for pain (0-100). Zero indicates no pain and 100 the worst pain imaginable.

    Time frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months

  15. Patient-reported Parameters

    VAS for swelling (0-100). Zero indicates no swelling and 100 the worst swelling imaginable.

    Time frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months

  16. Patient-reported Parameters

    VAS for difficulty of mouth opening (0-100). Zero indicates no difficulty of mouth opening and 100 complete inability to open mouth.

    Time frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months

Other outcomes

  1. Clinical Parameters

    gingival width

    Time frame: Measured at baseline (before surgery)

  2. Clinical Parameters

    gingival thickness

    Time frame: Measured at baseline (before surgery)

  3. Clinical Parameters

    wound opening

    Time frame: Measured immediately after surgery, at 1, 2 and 6 weeks and 4 months

  4. Clinical Parameters

    bleeding

    Time frame: Measured at 1, 2 and 6 weeks and 4 months

  5. Clinical Parameters

    grafting material discharge

    Time frame: Measured at 1, 2 and 6 weeks and 4 months

  6. Clinical Parameters

    flap necrosis

    Time frame: Measured at 1, 2 and 6 weeks and 4 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07372183
Lead sponsor
Marquette University
Collaborators
LifeNet Health
Responsible party
Vrisiis Kofina (Director, Advanced Education in Periodontics Program, Assistant Professor of Periodontics, Marquette University) — Principal investigator
First posted
Jan 28, 2026
Start date
Jan 25, 2026 (estimated)
Primary completion
Oct 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Jan 28, 2026

Study contacts

Vrisiis Kofina, DDS, MS
Contact
vrisiis.kofina@marquette.edu
516-817-0393
McKenna Schnack, DDS, MS
Contact
mckenna.schnack@marquette.edu
515-822-3552
Vrisiis Kofina, DDS, MS
principal investigator · Marquette University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion